{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:24:09Z","timestamp":1759775049020,"version":"3.41.2"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Kidney transplantation is a primary therapy for end-stage renal disease (ESRD) all the time. But it does not mean that we have fully unraveling the mystery of kidney transplantation and confer every patient favorable prognosis. Immune rejection has always been a stumbling block when we try to increase the success rate of kidney transplantation and improve long-term outcomes. Even if the immune rejection is effectively controlled in acute phase, there is a high possibility that the immune response mediated by chronically activated antibodies will trigger chronic rejection and ultimately lead to graft failure. At present, immunosuppressive agent prepared chemically is mainly used to prevent acute or chronic rejection, but it failed to increase the long-term survival rate of allografts or reduce the incidence of chronic rejection after acute rejection, and is accompanied by many adverse reactions. Therefore, many studies have begun to use immune cells to regulate the immune response in order to control allograft rejection. This article will focus on the latest study and prospects of more popular regulatory myeloid cells in the direction of renal transplantation immunotherapy and introduce their respective progress from experimental research to clinical research.<\/jats:p>","DOI":"10.3389\/fimmu.2021.625998","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T04:27:19Z","timestamp":1614140839000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["The Role of Regulatory Myeloid Cell Therapy in Renal Allograft Rejection"],"prefix":"10.3389","volume":"12","author":[{"given":"Jingming","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/BF01653562","article-title":"Reflections on the first successful kidney transplantation","volume":"6","author":"Murray","year":"1982","journal-title":"World J Surg."},{"key":"B2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev.pathmechdis.3.121806.151508","article-title":"Kidney transplantation: mechanisms of rejection and acceptance","volume":"3","author":"Cornell","year":"2008","journal-title":"Annu Rev Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"G. KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant."},{"key":"B4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1600-6143.2004.00332.x","article-title":"Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant."},{"key":"B5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1046\/j.1365-2702.1998.00189.x","article-title":"Quality of life after renal transplantation","volume":"7","author":"Fisher","year":"1998","journal-title":"J Clin Nurs."},{"key":"B6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000449020","article-title":"Bioavailability, efficacy and safety of generic immunosuppressive drugs for kidney transplantation: a systematic review and meta-analysis","volume":"44","author":"Tsipotis","year":"2016","journal-title":"Am J Nephrol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1001\/jamadermatol.2017.2984","article-title":"Long-term change in the risk of skin cancer after organ transplantation: a population-based nationwide cohort study","volume":"153","author":"Rizvi","year":"2017","journal-title":"JAMA Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.2215\/CJN.03510807","article-title":"Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result","volume":"3","author":"Srinivas","year":"2008","journal-title":"Clin J Am Soc Nephrol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2174\/1871530320999200831161710","article-title":"Acute versus chronic administration of calcineurin-inhibitors differen-tially affect T-cell function","author":"Kirchhof","year":"2020","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.gene.2017.10.081","article-title":"FOXP3 rs3761549 polymorphism predicts long-term renal allograft function in patients receiving cyclosporine-based immunosuppressive regimen","volume":"644","author":"Xu","year":"2018","journal-title":"Gene."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/TP.0b013e31823cab44","article-title":"Mechanisms of rejection: current perspectives","volume":"93","author":"Wood","year":"2012","journal-title":"Transplantation."},{"key":"B13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.autrev.2017.03.011","article-title":"Regulatory immune cells and functions in autoimmunity and transplantation immunology","volume":"16","author":"Papp","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nri3227","article-title":"Regulatory immune cells in transplantation","volume":"12","author":"Wood","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","article-title":"Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials","volume":"395","author":"Sawitzki","year":"2020","journal-title":"Lancet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1172\/JCI23743","article-title":"Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates","volume":"115","author":"Bashuda","year":"2005","journal-title":"J Clin Invest."},{"key":"B17","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.intimp.2010.11.001","article-title":"Adoptive transfer of CD4+CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys","volume":"11","author":"Ma","year":"2011","journal-title":"Int Immunopharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1182\/blood.V99.10.3493","article-title":"The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality","volume":"99","author":"Taylor","year":"2002","journal-title":"Blood."},{"key":"B19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nri1027","article-title":"Regulatory T cells in transplantation tolerance","volume":"3","author":"Wood","year":"2003","journal-title":"Nat Rev Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1111\/ajt.14415","article-title":"Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants","volume":"17","author":"Chandran","year":"2017","journal-title":"Am J Transplant."},{"key":"B21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/TP.0b013e3182a860de","article-title":"Regulatory myeloid cells in transplantation","volume":"97","author":"Rosborough","year":"2014","journal-title":"Transplantation."},{"key":"B22","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e12326","DOI":"10.1111\/xen.12326","article-title":"Human regulatory macrophages are potent in suppression of the xenoimmune response via indoleamine-2,3-dioxygenase-involved mechanism(s)","volume":"24","author":"Guo","year":"2017","journal-title":"Xenotransplantation."},{"key":"B24","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fimmu.2012.00218","article-title":"Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials","volume":"3","author":"Moreau","year":"2012","journal-title":"Front Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.3390\/ijms20184614","article-title":"Reparative and regenerative effects of mesenchymal stromal cells-promising potential for kidney transplantation?","volume":"20","author":"Pool","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/01.TP.0000083507.67995.13","article-title":"Macrophages act as effectors of tissue damage in acute renal allograft rejection","volume":"76","author":"Jose","year":"2003","journal-title":"Transplantation."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1172\/JCI74370","article-title":"Non-self recognition by monocytes initiates allograft rejection","volume":"124","author":"Oberbarnscheidt","year":"2014","journal-title":"J Clin Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1002\/eji.201141717","article-title":"Regulatory macrophages: setting the threshold for therapy","volume":"41","author":"Fleming","year":"2011","journal-title":"Eur J Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.immuni.2015.05.009","article-title":"DC-SIGN(+) macrophages control the induction of transplantation tolerance","volume":"42","author":"Conde","year":"2015","journal-title":"Immunity."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.4049\/jimmunol.1100762","article-title":"Cutting edge: immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients","volume":"187","author":"Hutchinson","year":"2011","journal-title":"J Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/mt.2012.168","article-title":"IFN-gamma-induced iNOS expression in mouse regulatory macrophages prolongs allograft survival in fully immunocompetent recipients","volume":"21","author":"Riquelme","year":"2013","journal-title":"Mol Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1038\/s41467-018-05167-8","article-title":"TIGIT(+) iTregs elicited by human regulatory macrophages control T cell immunity","volume":"9","author":"Riquelme","year":"2018","journal-title":"Nat Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3791\/54242","article-title":"Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity","author":"Ochando","year":"2017","journal-title":"J Vis Exp."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.cmet.2019.01.006","article-title":"IGF-2 preprograms maturing macrophages to acquire oxidative phosphorylation-dependent anti-inflammatory properties","volume":"29","author":"Du","year":"2019","journal-title":"Cell Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/TP.0b013e31820263b3","article-title":"Dendritic cells as a tool to induce transplantation tolerance: obstacles and opportunities","volume":"91","author":"van Kooten","year":"2011","journal-title":"Transplantation."},{"key":"B37","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nature06175","article-title":"Taking dendritic cells into medicine","volume":"449","author":"Steinman","year":"2007","journal-title":"Nature."},{"key":"B38","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nri2132","article-title":"Tolerogenic dendritic cells and the quest for transplant tolerance","volume":"7","author":"Morelli","year":"2007","journal-title":"Nat Rev Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1600-065X.2011.01015.x","article-title":"Dendritic cell control of tolerogenic responses","volume":"241","author":"Manicassamy","year":"2011","journal-title":"Immunol Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.cmet.2019.11.011","article-title":"Human tolerogenic dendritic cells regulate immune responses through lactate synthesis","volume":"30","author":"Marin","year":"2019","journal-title":"Cell Metab."},{"key":"B41","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.humimm.2017.10.017","article-title":"Regulatory dendritic cells for promotion of liver transplant operational tolerance: rationale for a clinical trial and accompanying mechanistic studies","volume":"79","author":"Thomson","year":"2018","journal-title":"Hum Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.stemcr.2017.03.020","article-title":"iPSC-derived regulatory dendritic cells inhibit allograft rejection by generating alloantigen-specific regulatory T cells","volume":"8","author":"Cai","year":"2017","journal-title":"Stem Cell Reports."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/ajt.12708","article-title":"Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentation","volume":"14","author":"Segovia","year":"2014","journal-title":"Am J Transplant."},{"key":"B44","doi-asserted-by":"publisher","first-page":"8911","DOI":"10.18632\/aging.102346","article-title":"Immature dendritic cells derived exosomes promotes immune tolerance by regulating T cell differentiation in renal transplantation","volume":"11","author":"Pang","year":"2019","journal-title":"Aging (Albany NY)."},{"key":"B45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fimmu.2016.00015","article-title":"Prospective clinical testing of regulatory dendritic cells in organ transplantation","volume":"7","author":"Thomson","year":"2016","journal-title":"Front Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"678","DOI":"10.4049\/jimmunol.166.1.678","article-title":"Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer","volume":"166","author":"Almand","year":"2001","journal-title":"J Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/MOT.0b013e3283401742","article-title":"Myeloid-derived suppressor cells in transplantation","volume":"15","author":"Dilek","year":"2010","journal-title":"Curr Opin Organ Transplant."},{"key":"B48","first-page":"95","article-title":"Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor","volume":"1","author":"Pak","year":"1995","journal-title":"Clin Cancer Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"7898","DOI":"10.4049\/jimmunol.180.12.7898","article-title":"Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion","volume":"180","author":"Dugast","year":"2008","journal-title":"J Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.4049\/jimmunol.1101512","article-title":"Control of transplant tolerance and intragraft regulatory T cell localization by myeloid-derived suppressor cells and CCL5","volume":"188","author":"Dilek","year":"2012","journal-title":"J Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1111\/ajt.12461","article-title":"Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion","volume":"13","author":"Luan","year":"2013","journal-title":"Am J Transplant."},{"key":"B52","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1189\/jlb.2HI1113-611RR","article-title":"Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide","volume":"96","author":"Liao","year":"2014","journal-title":"J Leukoc Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.transproceed.2015.10.060","article-title":"Myeloid-derived suppressor cells recruit CD4(+)\/Foxp3(+) regulatory T cells in a murine cardiac allograft","volume":"48","author":"Nakamura","year":"2016","journal-title":"Transplant Proc."},{"key":"B54","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fimmu.2018.00282","article-title":"Dexamethasone-induced myeloid-derived suppressor cells prolong allo cardiac graft survival through iNOS- and glucocorticoid receptor-dependent mechanism","volume":"9","author":"Zhao","year":"2018","journal-title":"Front Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.transproceed.2017.11.014","article-title":"Dexamethasone prolongs cardiac allograft survival in a murine model through myeloid-derived suppressor cells","volume":"50","author":"Nakao","year":"2018","journal-title":"Transplant Proc."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1007\/s10753-014-9910-5","article-title":"Clinical significance of myeloid-derived suppressor cells in human renal transplantation with acute T cell-mediated rejection","volume":"37","author":"Meng","year":"2014","journal-title":"Inflammation."},{"key":"B57","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.trim.2015.05.001","article-title":"Dynamic changes in myeloid derived suppressor cell subsets following renal transplant: a prospective study","volume":"32","author":"Hock","year":"2015","journal-title":"Transpl Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1111\/ajt.14718","article-title":"Myeloid-derived suppressor cells increase and inhibit donor-reactive T cell responses to graft intestinal epithelium in intestinal transplant patients","volume":"18","author":"Okano","year":"2018","journal-title":"Am J Transplant."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1111\/ajt.15879","article-title":"Myeloid-derived suppressor cells expand after transplantation and their augmentation increases graft survival","volume":"20","author":"Lee","year":"2020","journal-title":"Am J Transplant."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1097\/TP.0000000000003179","article-title":"Early posttransplant mobilization of monocytic myeloid-derived suppressor cell correlates with increase in soluble immunosuppressive factors and predicts cancer in kidney recipients","volume":"104","author":"Utrero-Rico","year":"2020","journal-title":"Transplantation."},{"key":"B61","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.humimm.2017.12.008","article-title":"Mesenchymal stromal cells for tolerance induction in organ transplantation","volume":"79","author":"Casiraghi","year":"2018","journal-title":"Hum Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/S2352-3026(15)00224-0","article-title":"Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis","volume":"3","author":"Hashmi","year":"2016","journal-title":"Lancet Haematol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/intimm\/dxx008","article-title":"Mesenchymal stromal cells and autoimmunity","volume":"29","author":"Pistoia","year":"2017","journal-title":"Int Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nri3209","article-title":"Multipotent mesenchymal stromal cells and the innate immune system","volume":"12","author":"Le Blanc","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","article-title":"Mesenchymal stromal cells: sensors and switchers of inflammation","volume":"13","author":"Bernardo","year":"2013","journal-title":"Cell Stem Cell."},{"key":"B66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/icb.2012.62","article-title":"Cellular and molecular interactions of mesenchymal stem cells in innate immunity","volume":"91","author":"Spaggiari","year":"2013","journal-title":"Immunol Cell Biol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","article-title":"Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells","volume":"105","author":"Jiang","year":"2005","journal-title":"Blood."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.4049\/jimmunol.177.4.2080","article-title":"Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells","volume":"177","author":"Nauta","year":"2006","journal-title":"J Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"17384","DOI":"10.1073\/pnas.1103650108","article-title":"Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells","volume":"108","author":"Chiesa","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B70","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1182\/blood-2007-10-119370","article-title":"Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses","volume":"112","author":"Karlsson","year":"2008","journal-title":"Blood."},{"key":"B71","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/scrt216","article-title":"Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells","volume":"4","author":"Luz-Crawford","year":"2013","journal-title":"Stem Cell Res Ther."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1097\/TP.0000000000001436","article-title":"CD4+CD25+ T regulatory cells in transplantation tolerance: 25 years on","volume":"100","author":"Hall","year":"2016","journal-title":"Transplantation."},{"key":"B73","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2174\/1574888X13666180912125736","article-title":"Mesenchymal stromal cells and natural killer cells: a complex story of love and hate","volume":"14","author":"Najar","year":"2019","journal-title":"Curr Stem Cell Res Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1089\/scd.2014.0155","article-title":"Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells","volume":"24","author":"Rosado","year":"2015","journal-title":"Stem Cells Dev."},{"key":"B75","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/tri.12132","article-title":"Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation","volume":"26","author":"Perico","year":"2013","journal-title":"Transpl Int."},{"key":"B76","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12967-018-1422-x","article-title":"Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial","volume":"16","author":"Sun","year":"2018","journal-title":"J Transl Med."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.625998\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T04:27:23Z","timestamp":1614140843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.625998\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":76,"alternative-id":["10.3389\/fimmu.2021.625998"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.625998","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2021,2,24]]},"article-number":"625998"}}